POCI$4.3001
Chart
Performance
Key Stats
AI POCI Summary
Powered by LiveAIAI Scoreboard
Powered by LiveAIOverall Analysis
HoldPrecision Optics Corporation (POCI) shows mixed signals. While it operates in a critical sector (medical instrumentation), its financial performance and technical indicators suggest a neutral to slightly cautious outlook. The company has positive aspects in its balance sheet but faces challenges with profitability and recent revenue trends.
Thematic
Precision Optics operates in the medical instrumentation sector, benefiting from ongoing demand for minimally invasive surgical tools and advanced imaging. However, it faces competition and the need for continuous innovation in a highly regulated market.
Fundamental
POCI shows a strong balance sheet with increasing assets and a stable debt level. However, profitability has been a concern, with recent periods showing net losses and negative net margins. Revenue has also seen a decline in the latest reported periods.
Technical
POCI's technical indicators show mixed signals. While some oscillators lean towards a buy or neutral stance, most moving averages indicate a bearish short-to-medium term trend. The stock is trading within its 52-week range but below its recent highs.
| Factor | Score |
|---|---|
| Medical Technology Demand | 85 |
| Innovation in Medical Imaging | 75 |
| Regulatory Environment | 50 |
| Industrial & Military Applications | 60 |
| Competitive Landscape | 55 |
| Factor | Score |
|---|---|
| Valuation | 50 |
| Profitability | 20 |
| Growth | 30 |
| Balance Sheet Health | 75 |
| Cash Flow | 25 |
| Factor | Score |
|---|---|
| Trend Analysis | 30 |
| Momentum | 50 |
| Volume Confirmation | 40 |
| Support & Resistance | 60 |
| Moving Averages | 35 |
AI Investing Checklist
Powered by LiveAIBullish Points (5)
Attractive Price-to-Sales (PS) Ratio
The Price-to-Sales (PS) ratio is 1.9, which is lower than the previous year's 2.2 and the trailing twelve months (TTM) of 2.9, suggesting potential undervaluation relative to revenue.
Positive Year-to-Date (YTD) Performance
The stock has shown a YTD performance of -4.19%, which, while negative, might be considered a buying opportunity if the underlying business fundamentals are strong and the market trend reverses.
Bearish Points (7)
Negative Net Income and Margin
The company has reported negative Net Income for the trailing twelve months (-$4,377,689) and for the latest annual period (-$2,951,377), with a negative net margin of -15.4% in the latest annual period, indicating significant unprofitability.
Negative Price-to-Earnings (PE) Ratio
The Price-to-Earnings (PE) ratio is negative (-8.4 TTM, -12.5 for 2024), which is a direct consequence of the company's unprofitability and highlights a significant valuation risk.
Calendar
September 2025
30
Next Earnings Date
H: $
A: $
L: $
Profile
Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States. The company offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. It also provides components and assemblies for industrial and military use. It markets its products to medical device companies. Precision Optics Corporation, Inc. was incorporated in 1982 and is based in Gardner, Massachusetts.